CAR-T Cell


Learn about:

CAR Domains & Generations

CAR-T Cells Manufacturing

Mechanism of Tumor Killing

Key Targets & Advances

CRISPR-Cas9 in Next-Gen CARs

Request Print Copy
CAR-T Cell

“This is always one of the most competitive categories in the awards, but

we’ve never seen one company get quite so many nominations as Bio-Techne did this year.

Clearly the company has a very loyal customer base, earned through providing excellent products.

Congratulations to Bio-Techne!” - Dr Andrew Chalmers, Founder of CiteAb

Read More
2018 CiteAb Researchers’ choice Bio-Techne

New Autophagy Research Area

Learn about autophagy signaling detection methods, & available modulators for your autophagy research.

new autophagy research area

Knockout Validation Reviews

Valid Now – 3/31/2018




Learn More
Knockout Validation Reviews - double points

Cleaner, Crisper Staining

Is Easier Than You Think

Vector® Mouse on Mouse (M.O.M.)

Immunodetection Kits

(Available within the U.S. only)

Learn More
Vector Immunodetection Kits

Scientific Resources

Autophagy Handbook

Refresh and expand your autophagy knowledge.

ICC Handbook

Learn about multicolor ICC/IF’s conceptual basics, protocols and troubleshooting.

IHC Handbook

Learn the basics of IHC, follow standard protocols, plus troubleshoot technical issues.

Andrew Leidal
Postdoc Interviews: Andrew Leidal, PhD
Andrew Leidal studies autophagy and its cross-talk with fundamental cellular functions including glycolytic flux and exosome loading. Learn about his path in science and the value of strong mentoring relationships.

direct vs indirect
Understanding direct vs. indirect detection
Learn the benefits and drawbacks of direct and indirect detection to help you make the right choice for your experiment.

Using blocking peptides
Using blocking peptides to assess antibody specificity.
Read more about blocking peptides and how you can use them as a method to assess antibody specificity.

By Jamshed Arslan Pharm.D.

von Hippel-Lindau (VHL) disease is associated with tumors arising in multiple organs. Activation of hypoxia-inducible factor (HIF)-alpha underlies the VHL disease pathogenesis. In normoxia, VHL tumor-suppressor protein (pVHL) and E3 ubiquitin ligase lead to...

Read More

By Christina Towers, PhD.

The current time from when a discovery is first made on the bench to when that discovery might translate into an approved therapy in cancer patients is an astounding 10-15 years. Scientists and clinicians alike face a daunting uphill battle to find novel targeted therapies that can improve a patient’s...

Read More